Drugmakers have been long suffering from high operational costs added to the price ceiling imposed by the Ministry of Health on their end products. In Today’s Story, we shed some light on the cost equation for operations as borne by drugmakers and its impact on their profitability historically and in CQ1 2019 ended 31 March 2019.
For more details, please read the full report below.

190530-Drugmakers’-Margins-Began-Recovery-in-Q1-2019